FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891825311> ?p ?o ?g. }

• W2891825311 endingPage "136" @default.
• W2891825311 startingPage "131" @default.
• W2891825311 abstract "IntroductionNeuroendocrine carcinoma (NEC) of the breast is a rare, special type of breast cancer, reportedly constituting 2% to 5% of all breast cancers. Although breast NEC does not have a specific targeted therapy, several new targeted therapies based on specific biomarkers were recently investigated in the NEC of lung and in other types of breast carcinoma, which may provide guidance to their feasibility in breast NEC.Materials and MethodsTwenty breast NECs were profiled for biomarkers of therapy including antibody-drug conjugates (DLL3, TROP-2, and FOLR1), histone deacetylase (H3K36Me3) inhibitors, tropomyosin receptor kinases (NTRK1/2/3 gene fusions) targeted inhibitors, alkylating agents (MGMT), and immune checkpoint inhibitors (PD-L1, TMB, and MSI) using immunohistochemistry and DNA/RNA next-generation sequencing assays.ResultsPredictive expression of TROP-2, FOLR1, and H3K36Me3 were detected in different subsets of tumors and may pave the way for development of novel targeted therapies in some patients with breast NECs. There was no evidence of DLL3 expression, NTRK gene fusions, or MGMT hypermethylation. No biomarkers predictive of immune checkpoint inhibitor efficacy (programmed death-ligand 1 expression, tumor mutational burden, microsatellite instability) were identified. FGFR and CCND1 gene amplifications were detected in isolated cases.ConclusionsThis study identified several potential targets for novel therapies in breast NEC, including farletuzumab and mirvetuximab soravtansine (FOLR1), sacituzumab govitecan (TROP-2), and HDAC inhibitors (H3K36Me3). In some cases, CCND1 gene amplification may indicate the usefulness of investigational therapies. The reported results should serve as an early indication of potential clinical relevance in selected patients with breast NEC." @default.
• W2891825311 created "2018-09-27" @default.
• W2891825311 creator A5024095283 @default.
• W2891825311 creator A5037644603 @default.
• W2891825311 creator A5046256229 @default.
• W2891825311 creator A5051355838 @default.
• W2891825311 creator A5062208753 @default.
• W2891825311 creator A5068394117 @default.
• W2891825311 creator A5069485497 @default.
• W2891825311 creator A5080544645 @default.
• W2891825311 date "2019-04-01" @default.
• W2891825311 modified "2023-10-17" @default.
• W2891825311 title "Potential Novel Therapy Targets in Neuroendocrine Carcinomas of the Breast" @default.
• W2891825311 cites W1514595034 @default.
• W2891825311 cites W1940241680 @default.
• W2891825311 cites W1982585181 @default.
• W2891825311 cites W2015645056 @default.
• W2891825311 cites W2016123658 @default.
• W2891825311 cites W2033912613 @default.
• W2891825311 cites W2039201797 @default.
• W2891825311 cites W2051608942 @default.
• W2891825311 cites W2092334961 @default.
• W2891825311 cites W2093128131 @default.
• W2891825311 cites W2096283457 @default.
• W2891825311 cites W2105604803 @default.
• W2891825311 cites W2107587681 @default.
• W2891825311 cites W2110578052 @default.
• W2891825311 cites W2127604631 @default.
• W2891825311 cites W2130735070 @default.
• W2891825311 cites W2134702979 @default.
• W2891825311 cites W2181205541 @default.
• W2891825311 cites W2230047757 @default.
• W2891825311 cites W2332190031 @default.
• W2891825311 cites W2474613389 @default.
• W2891825311 cites W2497079693 @default.
• W2891825311 cites W2514157276 @default.
• W2891825311 cites W2560431464 @default.
• W2891825311 cites W2560991366 @default.
• W2891825311 cites W2563442973 @default.
• W2891825311 cites W2564724316 @default.
• W2891825311 cites W2567395185 @default.
• W2891825311 cites W2580189873 @default.
• W2891825311 cites W2581473153 @default.
• W2891825311 cites W2587364318 @default.
• W2891825311 cites W2589656556 @default.
• W2891825311 cites W2595349270 @default.
• W2891825311 cites W2600975516 @default.
• W2891825311 cites W2603010884 @default.
• W2891825311 cites W2616923195 @default.
• W2891825311 cites W2752597428 @default.
• W2891825311 cites W2759003539 @default.
• W2891825311 cites W2763920317 @default.
• W2891825311 cites W2775566241 @default.
• W2891825311 cites W2784775153 @default.
• W2891825311 cites W2786037276 @default.
• W2891825311 cites W2789288884 @default.
• W2891825311 cites W2790164909 @default.
• W2891825311 cites W2792511820 @default.
• W2891825311 cites W2802596146 @default.
• W2891825311 cites W2803749679 @default.
• W2891825311 doi "https://doi.org/10.1016/j.clbc.2018.09.001" @default.
• W2891825311 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30268765" @default.
• W2891825311 hasPublicationYear "2019" @default.
• W2891825311 type Work @default.
• W2891825311 sameAs 2891825311 @default.
• W2891825311 citedByCount "35" @default.
• W2891825311 countsByYear W28918253112019 @default.
• W2891825311 countsByYear W28918253112020 @default.
• W2891825311 countsByYear W28918253112021 @default.
• W2891825311 countsByYear W28918253112022 @default.
• W2891825311 countsByYear W28918253112023 @default.
• W2891825311 crossrefType "journal-article" @default.
• W2891825311 hasAuthorship W2891825311A5024095283 @default.
• W2891825311 hasAuthorship W2891825311A5037644603 @default.
• W2891825311 hasAuthorship W2891825311A5046256229 @default.
• W2891825311 hasAuthorship W2891825311A5051355838 @default.
• W2891825311 hasAuthorship W2891825311A5062208753 @default.
• W2891825311 hasAuthorship W2891825311A5068394117 @default.
• W2891825311 hasAuthorship W2891825311A5069485497 @default.
• W2891825311 hasAuthorship W2891825311A5080544645 @default.
• W2891825311 hasBestOaLocation W28918253111 @default.
• W2891825311 hasConcept C121608353 @default.
• W2891825311 hasConcept C126322002 @default.
• W2891825311 hasConcept C143998085 @default.
• W2891825311 hasConcept C2781230642 @default.
• W2891825311 hasConcept C3018521938 @default.
• W2891825311 hasConcept C502942594 @default.
• W2891825311 hasConcept C530470458 @default.
• W2891825311 hasConcept C71924100 @default.
• W2891825311 hasConceptScore W2891825311C121608353 @default.
• W2891825311 hasConceptScore W2891825311C126322002 @default.
• W2891825311 hasConceptScore W2891825311C143998085 @default.
• W2891825311 hasConceptScore W2891825311C2781230642 @default.
• W2891825311 hasConceptScore W2891825311C3018521938 @default.
• W2891825311 hasConceptScore W2891825311C502942594 @default.
• W2891825311 hasConceptScore W2891825311C530470458 @default.
• W2891825311 hasConceptScore W2891825311C71924100 @default.
• W2891825311 hasIssue "2" @default.

• next